Sequencing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global sequencing market looks promising with opportunities in the biomarker & cancer, diagnostics, reproductive health, personalized medicines, and forensic applications. The global sequencing market is expected to grow with a CAGR of 16%-18% from 2020 to 2025. The major drivers for this market are rising applications of DNA sequencing and increasing genome mapping programs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global sequencing market report, please download the report brochure.
In this market, instruments is the largest product of sequencing pipe, whereas biomarker & cancer is the largest application. Growth in various segments of the sequencing market are given below:
The study includes trends and forecast for the global sequencing market by product, technology, platform, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ConsumablesInstrumentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Sequencing by SynthesisIon Semiconductor SequencingSequencing by ligationPyrosequencingSingle-molecule Real-time SequencingChain Termination TechnologyNanopore Sequencing
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
SangerNext Generation SequencingqPCROthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomarker & CancerDiagnosticsReproductive HealthPersonalized MedicineForensicsOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Government Research InstitutesPharmaceutical CompaniesBiotechnology CompaniesHospitals & ClinicsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the sequencing companies profiled in this report include Abbott Laboratories, Agilent Technologies, Danaher, Roche, Illumina, LI-COR Biosciences, Pacific Biosciences of California, Siemens, PerkinElmer, and Thermo Fisher Scientific.
Lucintel forecasts that instruments will remain the fastest growing product segment over the forecast period due to recent advancements in instruments for DNA sequencing.
Within this market, biomarker and cancer will remain the largest application segment over the forecast period due to increasing prevalance of cancer worldwide.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing awareness among people of personalized medicine.
Features of the Global Sequencing Market
Market Size Estimates: Global sequencing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global sequencing market size by various segments, such as product, technology, platform, application, and end user in terms of value.Regional Analysis: Global sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different products, technologies, platforms, applications, end users, and regions for the global sequencing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global sequencing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global sequencing market by product (consumables, instruments, and services ), technology (sequencing by synthesis, Ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination technology, and nanopore sequencing), platform (sanger, next generation sequencing, qPCR, and others), application (biomarker & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others), end user (academic & government research institutes, pharmaceutical companies, biotechnology companies, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global sequencing market?
Q.5 What are the business risks and threats to the global sequencing market?
Q.6 What are the emerging trends in the sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in the sequencing market?
Q.8 What are the new developments in the sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in the sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global sequencing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables, Instruments, and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-Time Sequencing, Chain Termination Technology, and Nanopore Sequencing), Platform (Sanger, Next Generation Sequencing, qPCR, and Others), Application (Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, And Others), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, and Germany), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global sequencing market looks promising with opportunities in the biomarker & cancer, diagnostics, reproductive health, personalized medicines, and forensic applications. The global sequencing market is expected to grow with a CAGR of 16%-18% from 2020 to 2025. The major drivers for this market are rising applications of DNA sequencing and increasing genome mapping programs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global sequencing market report, please download the report brochure.
In this market, instruments is the largest product of sequencing pipe, whereas biomarker & cancer is the largest application. Growth in various segments of the sequencing market are given below:
The study includes trends and forecast for the global sequencing market by product, technology, platform, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ConsumablesInstrumentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Sequencing by SynthesisIon Semiconductor SequencingSequencing by ligationPyrosequencingSingle-molecule Real-time SequencingChain Termination TechnologyNanopore Sequencing
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
SangerNext Generation SequencingqPCROthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomarker & CancerDiagnosticsReproductive HealthPersonalized MedicineForensicsOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Government Research InstitutesPharmaceutical CompaniesBiotechnology CompaniesHospitals & ClinicsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the sequencing companies profiled in this report include Abbott Laboratories, Agilent Technologies, Danaher, Roche, Illumina, LI-COR Biosciences, Pacific Biosciences of California, Siemens, PerkinElmer, and Thermo Fisher Scientific.
Lucintel forecasts that instruments will remain the fastest growing product segment over the forecast period due to recent advancements in instruments for DNA sequencing.
Within this market, biomarker and cancer will remain the largest application segment over the forecast period due to increasing prevalance of cancer worldwide.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing awareness among people of personalized medicine.
Features of the Global Sequencing Market
Market Size Estimates: Global sequencing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global sequencing market size by various segments, such as product, technology, platform, application, and end user in terms of value.Regional Analysis: Global sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different products, technologies, platforms, applications, end users, and regions for the global sequencing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global sequencing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global sequencing market by product (consumables, instruments, and services ), technology (sequencing by synthesis, Ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination technology, and nanopore sequencing), platform (sanger, next generation sequencing, qPCR, and others), application (biomarker & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others), end user (academic & government research institutes, pharmaceutical companies, biotechnology companies, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global sequencing market?
Q.5 What are the business risks and threats to the global sequencing market?
Q.6 What are the emerging trends in the sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in the sequencing market?
Q.8 What are the new developments in the sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in the sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global sequencing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables, Instruments, and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-Time Sequencing, Chain Termination Technology, and Nanopore Sequencing), Platform (Sanger, Next Generation Sequencing, qPCR, and Others), Application (Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, And Others), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, and Germany), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Sequencing Market Trends and Forecast
3.3: Global Sequencing Market by Product
3.3.1: Consumables
3.3.2: Instruments
3.3.3: Services
3.4: Global Sequencing Market by Technology
3.4.1: Sequencing by Synthesis
3.4.2: Ion Semiconductor Sequencing
3.4.3: Sequencing by ligation
3.4.4: Pyrosequencing
3.4.5: Single-molecule Real-time Sequencing
3.4.6: Chain Termination Technology
3.4.7: Nanopore Sequencing
3.5: Global Sequencing Market by Platform
3.5.1: Sanger
3.5.2: Next Generation Sequencing
3.5.3: PCR
3.5.4: Others
3.6: Global Sequencing Market by Application
3.6.1: Biomarker & Cancer
3.6.2: Diagnostics
3.6.3: Reproductive Health
3.6.4: Personalized Medicine
3.6.5: Forensics
3.6.6: Others
3.7: Global Sequencing Market by End User
3.7.1: Academic & Government Research Institutes
3.7.2: Pharmaceutical Companies
3.7.3: Biotechnology Companies
3.7.4: Hospitals & Clinics
3.7.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Sequencing Market by Region
4.2: North American Sequencing Market
4.2.1: Market by Product: Consumables, Instruments, and Services
4.2.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.2.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.2.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.2.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.2.6: The United States Sequencing Market
4.2.7: The Canadian Sequencing Market
4.2.8: The Mexican Sequencing Market
4.3: European Sequencing Market
4.3.1: Market by Product: Consumables, Instruments, and Services
4.3.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.3.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.3.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.3.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.3.6: The Sequencing Market of the United Kingdom
4.3.7: The Spanish Sequencing Market
4.3.8: The German Sequencing Market
4.4: APAC Sequencing Market
4.4.1: Market by Product: Consumables, Instruments, and Services
4.4.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.4.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.4.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.4.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.4.6: The Chinese Sequencing Market
4.4.7: The Indian Sequencing Market
4.4.8: The Japanese Sequencing Market
4.5: ROW Sequencing Market
4.5.1: Market by Product: Consumables, Instruments, and Services
4.5.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.5.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.5.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.5.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.5.6: Brazilian Sequencing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Sequencing Market by Product
7.1.2: Growth Opportunities for the Global Sequencing Market by Technology
7.1.3: Growth Opportunities for the Global Sequencing Market by Platform
7.1.4: Growth Opportunities for the Global Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Sequencing Market by End User
7.1.6: Growth Opportunities for the Global Sequencing Market by Region
7.2: Emerging Trends in the Global Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sequencing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott Laboratories
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: F. Hoffmann-La Roche Ltd.
8.5: Illumina, Inc.
8.6: LI-COR Biosciences, Inc.
8.7: Pacific Biosciences of California, Inc.
8.8: Siemens AG
8.9: PerkinElmer Inc.
8.10: Therm Fisher Scientific, Inc
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Sequencing Market Trends and Forecast
3.3: Global Sequencing Market by Product
3.3.1: Consumables
3.3.2: Instruments
3.3.3: Services
3.4: Global Sequencing Market by Technology
3.4.1: Sequencing by Synthesis
3.4.2: Ion Semiconductor Sequencing
3.4.3: Sequencing by ligation
3.4.4: Pyrosequencing
3.4.5: Single-molecule Real-time Sequencing
3.4.6: Chain Termination Technology
3.4.7: Nanopore Sequencing
3.5: Global Sequencing Market by Platform
3.5.1: Sanger
3.5.2: Next Generation Sequencing
3.5.3: PCR
3.5.4: Others
3.6: Global Sequencing Market by Application
3.6.1: Biomarker & Cancer
3.6.2: Diagnostics
3.6.3: Reproductive Health
3.6.4: Personalized Medicine
3.6.5: Forensics
3.6.6: Others
3.7: Global Sequencing Market by End User
3.7.1: Academic & Government Research Institutes
3.7.2: Pharmaceutical Companies
3.7.3: Biotechnology Companies
3.7.4: Hospitals & Clinics
3.7.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Sequencing Market by Region
4.2: North American Sequencing Market
4.2.1: Market by Product: Consumables, Instruments, and Services
4.2.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.2.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.2.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.2.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.2.6: The United States Sequencing Market
4.2.7: The Canadian Sequencing Market
4.2.8: The Mexican Sequencing Market
4.3: European Sequencing Market
4.3.1: Market by Product: Consumables, Instruments, and Services
4.3.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.3.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.3.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.3.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.3.6: The Sequencing Market of the United Kingdom
4.3.7: The Spanish Sequencing Market
4.3.8: The German Sequencing Market
4.4: APAC Sequencing Market
4.4.1: Market by Product: Consumables, Instruments, and Services
4.4.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.4.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.4.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.4.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.4.6: The Chinese Sequencing Market
4.4.7: The Indian Sequencing Market
4.4.8: The Japanese Sequencing Market
4.5: ROW Sequencing Market
4.5.1: Market by Product: Consumables, Instruments, and Services
4.5.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.5.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.5.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.5.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.5.6: Brazilian Sequencing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Sequencing Market by Product
7.1.2: Growth Opportunities for the Global Sequencing Market by Technology
7.1.3: Growth Opportunities for the Global Sequencing Market by Platform
7.1.4: Growth Opportunities for the Global Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Sequencing Market by End User
7.1.6: Growth Opportunities for the Global Sequencing Market by Region
7.2: Emerging Trends in the Global Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sequencing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott Laboratories
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: F. Hoffmann-La Roche Ltd.
8.5: Illumina, Inc.
8.6: LI-COR Biosciences, Inc.
8.7: Pacific Biosciences of California, Inc.
8.8: Siemens AG
8.9: PerkinElmer Inc.
8.10: Therm Fisher Scientific, Inc
